Nigel Brown, Ph.D.

Former Chief of Strategy, Covance

Dr. Nigel Brown, with over 25 years of experience in the pharmaceutical, biotech and contract research sectors, has executed more than 25 deals in the pharmaceutical R&D field, spanning acquisition, divestiture and strategic partnerships with combined transaction value in excess of $9 billion. He is extensively published in scientific and business literature, has advised governments on policy formulation related to pharmaceutical R&D, and has served on the boards of a number of biotech companies, including his role as Chairman of BioAxone Therapeutics.